|

Pectoralis Minor Release Versus Non-release in RSA

RECRUITINGN/ASponsored by Emory University
Actively Recruiting
PhaseN/A
SponsorEmory University
Started2024-08-07
Est. completion2026-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06292169

Summary

The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are: * whether releasing the pectoralis minor prophylactically could have better pain relief * whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes * whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients undergoing surgery for reverse total shoulder arthroplasty
* Patients willing and able to provide informed consent

Exclusion Criteria:

* Revision arthroplasty
* Reverse shoulder arthroplasty for proximal humerus fractures
* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers)
* Pregnant women
* Prisoners

Conditions4

Advanced Glenohumeral OsteoarthritisArthritisReverse Total Shoulder ArthroplastyRotator Cuff Tear Arthropathy

Locations2 sites

Emory Clinic
Atlanta, Georgia, 30322
Eric Wagner, MD404-778-7249eric.r.wagner@emory.edu
Emory Healthcare Orthopaedics and Spine Center
Atlanta, Georgia, 30329
Eric Wagner, MD404-778-7249Eric.r.wagner@emory.edu

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.